Evaluating a Structured Reporting Template to Increase Transparency and Reduce Review Time for Healthcare Database Studies

Focus Groups as Used by the Food and Drug Administration

Appendix A - List of Potential Stakeholders

Evaluating a Structured Reporting Template to Increase Transparency and Reduce Review Time for Healthcare Database Studies

OMB: 0910-0497

Document [docx]
Download: docx | pdf

OMB Control No. 0910-0497 Expiration date: 10/31/2020



APPENDIX A: POTENTIAL STAKEHOLDERS TO CONTACT REGARDING PARTICIPATION FROM MEMBERS OF THEIR ORGANIZATIONS (LIST MAY BE MODIFIED)



Name

Title

Organization

Large Distributed Healthcare Data Networks



Jeffrey Brown, Ph.D.

Director of Scientific Operations, Associate Professor, Department of Population Medicine, Harvard Medical School

PCORnet, FDA’s Sentinel Program

Richard Platt, M.D., M.Sc.

Principal Investigator, Chair of Department of Population Medicine, Harvard Medical School

PCORnet, FDA’s Sentinel Program

Payers, Healthcare Delivery Systems



Sarah Priddy Alwardt, Ph.D.

Vice President Health Informatics and HEOR

McKesson Specialty Health

Troyen Brennan, M.D.

Executive Vice President and Chief Medical Officer

CVS Health

Páll Jónsson, Ph.D., M.Res.

Associate Director Research and Development

NICE

Will Shrank, M.D.

Chief Medical Officer

UPMC

Sarah Emond MPP

Executive Vice President and Chief Operating Officer

ICER

Wim Goettsch PhD

HTA-advisor

Dutch National Healthcare Institute

Regulators



Peter Arlett, B.Sc., M.B.B.S., M.R.C.P., F.F.P.M.

Head of Pharmacovigilance and Epidemiology Department

European Medicines Agency (EMA)

Hans-Georg Eichler, M.D., M.Sc.

Senior Medical Officer

European Medicines Agency (EMA)

Yoshiaki Uyama, Ph.D.

Director, Office of Medical Informatics and Epidemiology

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

David Martin, M.D., M.P.H.

Liaison to the Reagan Udall Foundation IMEDS Program at U.S. FDA Center for Drug Evaluation and Research (CDER)

Food and Drug Administration (FDA)


Michael Nguyen, M.D.

FDA Sentinel Liaison, CDER

Food and Drug Administration (FDA)

Richard Swain, PhD

Acting Team Leader, Office of Surveillance and epidemiology, CDER

Food and Drug Administration (FDA)

Christian Hampp, PhD

Master Reviewer, Office of Surveillance and epidemiology, CDER

Food and Drug Administration (FDA)

Efe Eworuke, PhD

Team Leader, Office of Surveillance and epidemiology, CDER

Food and Drug Administration (FDA)

Clara Kim, PhD

Team Leader, Office of Translational Sciences, CDER

Food and Drug Administration (FDA)

Elande Baro, PhD

Statistical Reviewer, Office of Translational Science, CDER

Food and Drug Administration (FDA)

Stephanie Krauss, JD MPH

Regulatory Counsel, Office of Regulatory Policy, CDER

Food and Drug Administration (FDA)

Open Science



John Ioannidis, M.D., D.Sc.

Co-Director, Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine

Meta-Research Innovation Center at Stanford

Brian Nosek, Ph.D.

Executive Director, Professor of Psychology, University of Virginia

Center for Open Science

Journal Editors



Sean Hennessy, Pharm.D., Ph.D.

Professor of Epidemiology and of Systems Pharmacology and Translational Therapeutics

University of Pennsylvania Perelman School of Medicine

Laura Happe

Editor in Chief of Journal of Managed Care and Specialty Pharmacy

Journal of Managed Care and Specialty Pharmacy

Christine Laine, M.D., M.P.H., F.A.C.P.

Editor in Chief, Associate Professor, Jefferson Medical College

Annals of Internal Medicine

Elizabeth Loder, M.D., M.P.H.

Head of Research, BMJ, Professor of Neurology, Harvard Medical School

BMJ

Henrik Toft Sørensen, M.D., Ph.D.

Editor in Chief

Clinical Epidemiology

Peter Tugwell, M.Sc., M.D., F.R.C.P.C.

North American Editor, Professor of Medicine and Epidemiology & Community Medicine at the University of Ottawa

Journal of Clinical Epidemiology

Wolfgang Winkelmayer, M.D., M.P.H., Sc.D., F.A.S.N.

Associate Editor, Professor of Medicine and Chief, Section of Nephrology, Baylor College of Medicine

Journal of the American Medical Association (JAMA)

Professional Society/Guidelines



Jesper Hallas, M.D., Ph.D.

President

ISPE

Sinead Langan PhD

Wellcome Senior Clinical Fellow and Professor

RECORD guidelines

Dick Willke, Ph.D.

Chief Scientific Officer

ISPOR

International Network of Academics



K. Arnold Chan, M.D., Sc.D.

Director, Health Data Research Center

National Taiwan University

Nam-Kyong Choi, B. Pharm., Ph.D.

Assistant Professor, Korea Institute of Drug Safety & Risk Management (KIDS) Advisor, Asian Pharmacoepidemiology Network (AsPEN) Chair-Elect

Ewha Womans University

Frank de Vries, Pharm.D., Ph.D.

Head of Research

Department of Clinical Pharmacy, Maastricht UMC+

The Netherlands

Contract Research Organization



Alison Bourke, M.Sc., F.R.Pharm.S.

Scientific Director, Real World Insights, QuintilesIMS

QuintilesIMS

John Seeger, Pharm.D., Dr.P.H.

Chief Scientific Officer

Optum Epidemiology


Name

Title

Organization

Pharmaceutical Industry



Dorothee Bartels, M.Sc., Ph.D.

Head of Global Epidemiology

Boehringer Ingelheim GmbH

Andrew Bate, Ph.D.

Senior Director, Analytics Team Lead in Epidemiology

Pfizer

Brian Bradbury, D.Sc.

Executive Director, Center for Observational Research 

Amgen

Javier Jimenez, M.D., M.P.H.

VP, Global Head RWE and Clinical Outcomes 

Sanofi

Kris Kahler, Ph.D.

Executive Director and the Global Head of Outcomes Evidence & Analytics

Novartis

Joanne Waldstreicher, M.D.

Chief Medical Officer

Johnson & Johnson

















11

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorOpper, Gretchen
File Modified0000-00-00
File Created2021-01-15

© 2024 OMB.report | Privacy Policy